Apr 29, 21 · Dr David T Rubin and His Colleagues Discuss COVID19 Vaccines for Patients with IBD;Dr Rubin Discusses Advances in AntiCytokine Therapy The Current and Potential Role of IL12/23 and IL23 Inhibitors in the Treatment of IBD;We report efficacy of BMS in IL23–mediated conditions two inflammatory bowel disease (IBD) models in mice and plaque psoriasis (PsO) in a Phase (Ph) 2 clinical trial, providing evidence that TYK2 inhibition is an attractive therapeutic target for a range of autoimmune diseases
All Are Equal Some Are More Equal Targeting Il 12 And 23 In Ibd Nda Itt